|
Bendamustine Hydrochloride Clinical Trials
3 actively recruiting trials across 1 location
Also known as: Bendamustin Hydrochloride, Bendeka, Cytostasan Hydrochloride, Levact, Ribomustin +3 more
Pipeline
Phase 2: 3
Top Sponsors
- University Health Network, Toronto1
- St. Petersburg State Pavlov Medical University1
- Joseph Tuscano1
Indications
- Cancer3
- Classical Hodgkin Lymphoma1
- Refractory Follicular Lymphoma1
- Recurrent Follicular Lymphoma1
- Refractory Cancer1
Other2 trials
Sacramento, California1 trial
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
University of California Davis Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.